CALC CalciMedica Inc
3,593
| 52-Wk High | $0.00 |
| 52-Wk Low | $0.00 |
CalciMedica (NASDAQ:CALC) Stock Price Down 4%Zolmax • 8 days ago
CalciMedica, Inc. (NASDAQ:CALC Get Free Report) dropped 4% on Friday . The company traded as low as $2.60 and last traded at $2.64. Approximately 8,990 shares changed hands during trading, a...
Share to Feed
CalciMedica Announces Upcoming Presentations and Events in September CalciMedica Announces Upcoming Presentations and Events in September PR Newswire LA JOLLA, Calif., Sept. 6, 2023 LA JOLLA, Calif...
CalciMedica, Inc. (NASDAQ:CALC Get Free Report) shares traded up 3% on Thursday . The company traded as high as $3.11 and last traded at $3.11. 3,326 shares were traded during trading, a...
CalciMedica, Inc. (NASDAQ:CALC Get Free Report) shares rose 3% during mid-day trading on Thursday . The company traded as high as $3.11 and last traded at $3.11. Approximately 3,326 shares...
CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023 CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023 PR Newswire LA JOLLA, Calif., Aug. 31, 2023 LA JOLLA, Calif., Aug. 31, 2023 /PRNewswire/ -- CalciMedica Inc...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
International expansion of CARPO, a Phase 2b clinical trial of Auxora in acute pancreatitis patients with accompanying systemic inflammatory response syndrome (SIRS), in India Expansion of team with key leadership appointments in regulatory and clinical development Filing of an investigational new ...
Bellicum Pharmaceuticals (NASDAQ:BLCM Get Rating) and CalciMedica (NASDAQ:CALC Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional...
BOSTON, May 23, 2023 (GLOBE NEWSWIRE) -- Life Biosciences (Life Bio), a biotechnology company advancing innovative cellular rejuvenation platforms to reverse diseases of aging and injury and ultimately restore health for patients, today announced the appointment of Ming Yang, Ph.D., as Senior Vice ...
